Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Four Indian generic companies take sub license from MPP on daclatasvir
Hepatitis C vaccine fails to prevent chronic infections
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
Stage set for access to Hepatitis C treatment in Malaysia
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Part 2: How is hepatitis C treated?
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
